Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy
- 1 November 1985
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (5) , 24-37
- https://doi.org/10.1016/0002-9343(85)90507-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetesMetabolism, 1986
- A Controlled Trial of Sorbinil, an Aldose Reductase Inhibitor, in Chronic Painful Diabetic NeuropathyDiabetes, 1983
- TREATMENT OF SEVERELY PAINFUL DIABETIC NEUROPATHY WITH AN ALDOSE REDUCTASE INHIBITOR: RELIEF OF PAIN AND IMPROVED SOMATIC AND AUTONOMIC NERVE FUNCTIONThe Lancet, 1983
- Aldose Reductase Inhibition Improves Nerve Conduction Velocity in Diabetic PatientsNew England Journal of Medicine, 1983
- Kinetics of an orally absorbed aldose reductase inhibitor, sorbinilClinical Pharmacology & Therapeutics, 1981
- Effects of aldose reductase inhibitor treatment in diabetic polyneuropathy - a clinical and neurophysiological study.Journal of Neurology, Neurosurgery & Psychiatry, 1981
- Diabetic neuropathy and plasma glucose controlThe American Journal of Medicine, 1981
- Assessment of Cardiovascular Effects in Diabetic Autonomic Neuropathy and Prognostic ImplicationsAnnals of Internal Medicine, 1980
- Diabetic autonomic neuropathyDiabetologia, 1979
- CP-45,634: A novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic ratsMetabolism, 1979